Objective: Collateral expansion is an important compensatory mechanism to alleviate tissue ischemia after arterial occlusion. We investigated the efficacy and mechanisms of temporary remote hindlimb occlusion to stimulate contralateral blood flow and collateral expansion after hindlimb ischemia in mice and evaluated translation to peripheral artery disease in humans. Methods and results: We induced unilateral hindlimb ischemia via femoral artery excision in mice. We studied central hemodynamics, blood flow, and perfusion of the ischemic hindlimb during single and repetitive remote occlusion (RRO) of the contralateral non-ischemic hindlimb with a pressurized cuff. Similar experiments were performed in patients with unilateral peripheral artery disease (PAD). Contralateral occlusion of the non-ischemic hindlimb led to an acute increase in blood flow to the ischemic hindlimb without affecting central blood pressure and cardiac output. The increase in blood flow was sustained even after deflation of the pressure cuff. RRO over 12 days (8/day, each 5 min) led to significantly increased arterial inflow, lumen expansion of collateral arteries, and increased perfusion of the chronically ischemic hindlimb as compared to control. In NOS3 -/-and after inhibition of NOS (L-NAME), and NO (ODQ), the acute and chronic effects of contralateral occlusion were abrogated and stimulation of guanylyl cyclase with cinaciguate exhibited a similar response as RRO and was not additive. Pilot studies in PAD patients demonstrated that contralateral occlusion increased arterial inflow to ischemic limbs and improved walking distance. Conclusions: Repetitive remote contralateral occlusion stimulates arterial inflow, perfusion, and functional collateral expansion in chronic hindlimb ischemia via an eNOS-dependent mechanism underscoring the potential of remote occlusion as a novel treatment option in peripheral artery disease.
Introduction
Repetitive ischemia via transient occlusion of inflow into extremities has been shown to protect from detrimental ischemia in remote organs such as the heart or the lung [1] [2] [3] [4] [5] [6] , indicating that interorgan communication plays an important role within the cardiovascular system. This approach has been used therapeutically to improve the outcome of myocardial infarction. Depending on the time of remote occlusion it is referred to remote as pre-, per-, or post-conditioning relative to onset of e.g. cardiac ischemia: before, during, or after [7] . For instance, repetitive occlusion and ischemia to an arm or a leg with a simple blood pressure cuff can decrease infarct size when performed before, during, or after re-establishment of blood flow to occluded coronary arteries in the context of myocardial infarction. The underlying signaling mechanisms, however, remain incompletely understood. This relates particularly to the mechanism by which the protective signal is transferred from the remote site to the target organ. Many pathways have been forwarded but none can explain the protective effects completely. It has been proposed that soluble mediators, in particular nitrite, released from the limbs after cessation of temporal ischemia could account for cardioprotection by remote ischemic conditioning [8] .
In the context of peripheral artery disease (PAD), collateral growth (arteriogenesis) represents a promising therapeutic target. Arteriogenesis is the only form of vascular growth that leads to development and expansion of large conducting vessels compensating for blood flow deficits caused by complete occlusion of a main conduit artery. Exercise training is the only proven therapy to enhance arteriogenesis. During this process, pre-existing arterio-arterial anastomoses develop into a functional collateral network. The mechanisms linking exercise training with arteriogenesis are also not fully understood. However, it is believed that the major driving force of arteriogenesis is an increased unidirectional flow through these pre-existing arteriolar connections that evolves through a pre-and post-occlusive pressure gradient, which is increased during exercise of a diseased limb. As a consequence, the increased fluid wall shear stress (WSS) in the developing collaterals triggers a positive remodeling process leading to lumen expansion and increased conductance [9] [10] [11] [12] . WSS-triggered localized activation of the endothelium leads to an acute NOS3-dependent vasodilation, which is followed by a cellular edema, monocyte homing, matrix degradation, and upregulation of adhesion molecules, mitogenic-, thrombogenic-, and fibrinolytic factors [13] [14] [15] . Interestingly, not only walking exercise but also exercise training with a hand treadmill can increase perfusion of the legs [16] . While the mechanism of this is unknown, it is tempting to hypothesize that arteriogenesis in one chronically ischemic extremity can be stimulated via interorgan communication by intermittent acute occlusive cues in another remote extremity.
We, therefore, hypothesized that the blood flow to one chronically ischemic hindlimb can be acutely increased by temporal occlusion of the contralateral non-ischemic hindlimb and, when applied repetitively, thereby promote collateral expansion in the chronically ischemic limb in mice. In order to investigate whether this approach may be applicable to humans, we performed proof-of-concept studies in patients with PAD.
Material and methods
In order to investigate the hypothesis, four study series were performed (Fig. 1 ). Series 1: Acute hemodynamic changes during remote occlusion of the contralateral healthy hindlimb in the murine model of hindlimb ischemia. Parameters investigated before, during, and up to after 5 min occlusion period were: cardiac stroke volume (SV), heart rate (HR), central blood pressure (BP), blood flow velocity, diameter, blood flow, and wall shear stress (WSS) of the common iliac artery (CIA) as well as tissue perfusion of both hindlimbs (n = 8 WT mice). Series 2: Chronic effect of repetitive remote occlusion (RRO) on collateral growth in the murine model of hindlimb ischemia. Repetitive occlusion of the healthy hindlimb with a vascular occluder cuff (200 mmHg) or control sham (0 mmHg cuff) was performed over 5 min, 8 × /day over 12 days. Measurements of flow velocity, diameter, blood flow, and WSS of the CIA, common femoral artery (CFA), and caudal femoral arteries (CA) of both hindlimbs were taken before (day −1), on day 2, and day 14 after induction of hindlimb ischemia, paralleled by laser Doppler perfusion imaging of both hindlimbs on day −1, 0, 3, 5, 7, and 14. The lumen diameter of the CA and collateral vessel (gracilis artery, GA) was determined by vascular cast analysis on day 14. Besides wild type (WT) mice (n = 16), parallel experiments were performed in NOS3 -/-(n = 16), L-NAME treated WT mice (n = 16), ODQ treated WT mice (n = 16), and cinaciguat treated WT mice (n = 16). Series 3: Acute impact of remote occlusion on femoral artery blood flow in humans with known atherosclerotic disease. Before, during and after a period of 5 min inflation of a blood pressure cuff placed around the thigh (pressure 200 mmHg) the following readings of the contralateral CFA were documented: flow velocity, diameter, blood flow, and WSS. Series 4: Impact of chronic RRO on walking distance in PAD patients. PAD patients with known unilateral, isolated, occlusion of the SFA and an impaired walking capacity performed RRO at home over 12 weeks. Investigated was the change in walking distance in a 6 min walking test on day 1 and after 3 months of RRO.
Animals
Male C57BL/6 wild type (WT; n = 40) and NOS3 −/− -mice (endothelial nitric oxide synthase) (C57BL/6.129/Ola-eNOStm) [17] were kept according to federal regulations. All procedures were performed in accordance with the national guidelines on animal care and were approved by the local Research Board for animal experimentation (LANUV = State Agency for Nature, Environment and Consumer Protection). Mice ranged in body weight from 20 to 30 g and in age from 10 to 12 weeks. Animals received a standard diet and water ad libitum. In series 2, mice were allocated into groups as follows: WT, WT + L-NAME (Nω-Nitro-L-arginine methyl ester hydrochloride,1 mg/kg ad libitum, Sigma),
-a]quinoxalin-1-one,10 mg/kg ad s.c., Sigma), WT + cinaciguat (0.03 mg/kg ad libitum, Sigma). Furthermore, each group (n = 16) was divided into control animals (sham RRO, no cuff occlusion) and mice being subjected to RRO interventions.
Model of hindlimb ischemia and perfusion measurements by laser Doppler
The mice were anesthetized by intraperitoneal injection of 100 mg/ kg ketamine and 10 mg/kg xylazine, and hindlimb ischemia was induced by ligation of the femoral artery directly distal to the superficial epigastric artery (Fig. 1A) . In preparation for the ligation, hair from the medial side of the left thigh was removed with a depilatory crème and a skin incision was performed to expose the femoral artery. The vein and nerve running adjacent to the artery were gently separated from the artery with a forceps. Further, a second ligation was placed around the lateral circumflex artery to diminish femoral artery run-off. The animals recovered over two weeks and blood flow recovery was assessed at 2 h and at days 3, 5, 7, and 14 postoperatively by laser Doppler perfusion imaging (LDPI, Perimed, Stockholm, Sweden; Fig. 1C ). The lower hindlimb including the sole served as the region of interest were perfusion was measured. The perfusion of the ischemic and non-ischemic limb was calculated on the basis of color-coded histogram pixels. Changes in perfusion in each measurement were calculated as ratio to preoperative perfusion levels of each hindlimb. Measurements were performed under isoflurane anesthesia (5 vol.-% induction and 2 vol.-% maintenance) with mice being placed on a heating pad to maintain a constant body temperature of 37°C.
Assessment of blood flow
Vascular diameter and flow velocity were assessed as described previously [18] with the use of the high-frequency, high-resolution digital VisualSonics imaging platform Vevo 2100 (Visual Sonics Inc., Toronto, Canada; Fig. 1B ). In brief, prior to induction of hindlimb ischemia and on the 14th postoperative day, mice were anesthetized with isoflurane. Body core temperature was kept at 37°C or within ± 1°C by using a heated examination table that was also equipped with ECG electrodes that documented heart rates of 400-500 bpm, and a breathing rate of about 100 breaths per minute. The fur was removed from the hindlimbs and the lower abdomen and prewarmed ultrasound gel was applied in access to the pelvis. The ultrasound probe (30-70 MHz linear array microscan transducer, VisualSonics) was attached to a stereotactic holder and was manually aligned with the vessel. Blood flow was assessed in both hindlimbs in three successive vessels along the hindlimb vascular tree, being from proximal to distal: common iliac artery (CIA), common femoral artery (CFA) and caudal femoral artery (CA). Online monitoring of blood flow velocity and heart rate by pulsed-wave (PW) Doppler was displayed as spectral Doppler curves. Offline analysis of acquired images was performed from (caption on next page) recorded loops using a semiautomated system (Brachial Analyzer, MIA, Iowa City) as described by Heiss et al. [19] . All diameter readings were taken at end diastole to limit the influence of potential differences in vascular compliance on diameter measurements. After recording of each vessel´s lumen diameter (d), the cross-sectional vessel area (A) was calculated as follows:
. Angle-corrected blood flow velocity was measured with the pulsed Doppler sample volume expanded to encompass 2/3 of the vessel diameter. WSS was calculated as 8*μ* mean flow-velocity (V) / mean diameter, where blood viscosity (μ) was assumed to be constant at 0.035 dyn/sec * cm 2 . The time-averaged mean blood flow velocity (FV) was automatically calculated by the system over 3 complete cardiac cycles. Blood flow (Q) was calculated as follows: Q = A * FV.
Assessment of cardiac function and aortic blood pressure
In series 1, cardiac imaging was carried out by using a high-resolution linear ultrasound probe (18-38 MHz; Vevo 2100, Visual Sonics Inc., Toronto, Canada), and the manufacturer's analysis software. Echocardiography was performed as previously described [20] . LV volume, stroke volume (SV), cardiac output (CO) and ejection fraction (EF) were calculated in B-mode by identification of maximal and minimal cross-sectional area. Additionally, LV systolic function was determined as fractional shortening (FS) in the longitudinal axis. Assessment of aortic blood pressure was assessed invasively by a 1.4 F Millar pressure catheter (SPR-839, Millar Instrument, Houston, TX, USA). Mice were anesthetized with ketamine and xylazine. For mean arterial pressure assessment, the catheter was placed into the ascending aorta. After an equilibration period, baseline blood pressure readings were recorded by IOX Software (EMKA) and a vascular occluder, previously attached to the contralateral thigh, was inflated to 200 mmHg to achieve vascular occlusion. Pressure was kept constant over 5 min. Blood pressure was recorded simultaneously over the time of occlusion and beyond.
Repetitive remote occlusion (RRO)
On the second postoperative day (series 2), mice that were subjected to hindlimb ischemia induction were kept under isoflurane anesthesia and placed on a heating plate to maintain body temperature of 37°C. In the following, a vascular occluder (8 mm diameter, Harvard Apparatus, Harvard, Boston, MA, USA) was placed around the contralateral, healthy upper hindlimb and inflated to 200 mmHg to abrogate blood flow. The pressure was kept constant over 5 min (Druckkalibriergerät KAL 84,Halstrup Walcher, Kirchzarten, Germany) and released immediately thereafter, followed by a 5 min period of rest. The interval was repeated 8 times/day for the following 12 days. Operated control mice were merely put under daily isoflurane anesthesia for identical time periods.
Visualization of collateral arteries by vascular cast
On day 14 after induction of hindlimb ischemia (series 2), mice were anesthetized by i.p. injection of 100 mg/kg ketamine and 10 mg/ kg xylazine, and anticoagulated with heparin (250 IU i.p.). The thoracic cavity was opened, rapidly exposing the heart. Prior to initiating perfusion, the right atrium was opened to serve as a drain vent. The animals were perfused with Microfil medium mixture (Microfil MV-122, Flow Tech; Carver, MA) in antegrade direction through the thoracic aorta at 3 ml/min, until all organs showed a rich yellow coloration. To avoid backflow of medium mixture the thoracic aorta was ligated directly distal to the location of needle penetration. The specimens were placed at 4°C overnight, to allow polymerization. Mouse hindlimbs were dissected from the specimens and dehydrated in a graded series of alcohol solutions (25%, 50%, 75%, 95%, and 100% ethanol) for 12 h in each alcohol dilution, followed by immersion in an alcohol-methyl salicylate clearing sequence according to manufacturer´s instructions. After seven days, the hindlimb tissue was sufficiently cleared in order to record collateral vessels using Diskus software (Hilgers, Koenigswinter, Germany). Finally, the assessment of collateral vessel size was performed using Photoshop software (Adobe).
Human proof-of-concept studies
In order to assess the human and clinical relevance of our experimental findings, we aimed to investigate the effect of RRO in 2 human proof of concept studies. In the first study (series 3) and similar to the first animal study described above, volunteers (n = 8) with known atherosclerotic disease were subjected to unilateral cuff inflation on the thigh (pressure 200 mmHg) over 5 min following a 5 min rest in supine position. Using color duplex sonography, diameters, and flow velocity readings of the contralateral CFA were measured simultaneously, during cuff occlusion and over 4 min after cuff deflation.
In the second human study (series 4), we included patients with documented PAD and isolated, unilateral occlusion of the superficial femoral artery (SFA). Inclusion criteria were ankle-brachial index (ABI) of < 0.9; and isolated hemodynamically relevant > 70% stenosis of SFA, as measured by intrastenotic peak systolic velocity ratio of > 3.4 and characteristic poststenotic Doppler spectrum lacking a dip. Subjects (N = 8) were randomly allocated to the RRO-or control-group. Individuals of the RRO-group were instructed to perform RRO with a blood pressure cuff at home (repetitive cuff inflation to 200 mmHg on the contralateral thigh) over 12 weeks (every other day over five minutes followed by five minutes rest, 4x /day). On day one and after 12 weeks patients were tested for maximum walking distance in a 6-min walking test. The study protocol was approved by the ethics committee of the Heinrich Heine University Duesseldorf, and all participants gave written informed consent.
Statistical analyses
Statistical analyses were performed with Prism 6.0 for Mac OS X, GraphPad Software Inc. Group differences were calculated with repeated measurements ANOVA and consecutive post hoc test when more than 2 groups were compared or t-test if only 2 groups were compared. Within Group differences were calculated by repeated measurements ANOVA or paired t-test if only 2 groups were compared. P-values of less than 0.05 were regarded as significant. All data are presented as mean ± standard deviation. (BL = baseline; BP = aortic blood pressure; CIA = common iliac artery; CFA = common femoral artery; CA = causal femoral artery; GA = gracilis artery; HR = heart rate; OP = surgery/operation; SV = stroke volume; WSS = wall shear stress).
Results

Remote occlusion increases perfusion of contralateral chronically ischemic hindlimb during ischemia without affecting central hemodynamics
After inducing unilateral hindlimb ischemia, we first investigated the acute hemodynamic effects of remote occlusion by inflating a cuff around the thigh of the contralateral healthy hindlimb (series 1). Cuff inflation over 5 min led to an immediate complete abrogation of blood flow in the healthy hindlimb (Fig. 2) . During cuff occlusion, we observed an increase in blood flow velocity and WSS in CIA at 60 s that was followed by an increase in CIA diameter and blood flow in the opposite ischemic hindlimb. Consequently, these changes resulted in an increase in tissue perfusion in the adductor muscle region that peaked at 120 s and plateaued thereafter. This indicates an almost immediate microvascular vasodilation that is followed by flow-mediated vasodilation of upstream conduit arteries during occlusion. In parallel, we evaluated potential central hemodynamic effects of unilateral cuff occlusion and ischemia. Importantly, the heart rate, cardiac output, and central aortic blood pressure remained unaffected throughout the occlusion, indicating the increase in perfusion cannot be explained by central hemodynamic effects such as higher blood pressure. After reperfusion of the healthy hindlimb, the perfusion of the chronically ischemic hindlimb remained increased over 2 min.
Repetitive remote occlusion stimulates arteriogenesis in an eNOSdependent manner
According to our hypothesis, that enhanced WSS due to increased blood flow is the trigger to promote collateral expansion, we investigated the effect of RRO on arteriogenesis in the hindlimb model (series 2). At day 2 after induction of hindlimb ischemia, mice were subjected to repetitive remote occlusion or sham occlusion in the contralateral non-ischemic hindlimb (8 times daily, 5 min each, 12 days, 200 mmHg or 0 mmHg [control]). Importantly, limb loss (max. 2 toes) occurred in two NOS3
−/− -mice and two WT-mice receiving L-NAME with all of them allocated to the sham occlusion control groups. Arterial lumen expansion was characterized in both hindlimbs at day 14 after induction of unilateral hindlimb ischemia using the microfil cast technique. The analyzed vessel segments were the CA representing the upstream artery supplying the collateral bed and the gracilis artery (GA) representing a collateral artery itself ( Figs. 1 and 3 ; Table 1 ). In the control group (0 mmHg), both, the diameter of CA and GA increased significantly by 24 ± 3.3% (p = 0.0004) and 61 ± 5.6% (p < 0.0001), respectively, as compared to the vessel diameter in the contralateral non-operated hindlimb. RRO led to a significantly greater lumen expansion in both CA by 34 ± 3.9% (p < 0.0001) and the GA 101 ± 6% (p < 0.0001).
In the control group (0 mmHg), the increase in collateral expansion was considerably blocked in mice being treated with L-NAME and in NOS3 −/− -mice, and the effect of RRO-intervention on collateral expansion was also largely blunted in these both groups. Interestingly, the percentage of RRO stimulated arterial lumen expansion ascribed to eNOS was significantly larger in the GA as compared to the CA. We further observed that the effect seen in CA and GA was also present in the dorsal vascular run-off where the iliaco-femoral artery supplies the dorsal hindlimb via the gluteal artery that in turn feeds into a collateral artery to the lateral hindlimb (data not shown).
Repetitive remote occlusion increases net blood flow to the ischemic hindlimb
To link the arteriogenic process observed in the microscopic vessel cast analysis described above with a hemodynamic correlate, blood flow was analyzed within the concerned vascular tree (CIA, CFA, CA) with ultrasound (series 2).
At day 14 after induction of hindlimb ischemia, WT mice showed a significantly increased blood flow in all three vessels of the operated hindlimb as compared to the blood flow observed on the 2nd post-operative day (Δ increase CIA 14 ± 4%, p < 0.0001; Table 2 ; Fig. 4 ). In parallel, the blood flow of the contralateral hindlimb arteries decreased, likely due to volume re-distributional effects in favor of the operated hindlimb (Δ decrease CIA −10 ± 5.8%, p < 0.05). However, the increase in blood flow in the operated hindlimb of mice was significantly greater in animals that had been subjected to RRO (CIA 27 ± 5%, p < 0.0001). No significant increase was observed when L-NAME was applied and concomitant application of repetitive occlusion in this group did not have any positive effect in this regard. Although eNOS3 −/− -mice also showed a significant increase in blood flow on day 14, values were significantly lower compared to WT mice and RRO could not compensate for the discrepancy.
With regard to the net flow over the collateral vessels the additional blood volume that runs via the collateral circulation was greatest in the WT group subjected to RRO (Δ flow: CIA 199 ± 41 µl/min vs. CA 60 ± 11 µl/min; WT control: CIA 89 ± 6 µl/min vs. CA 26 ± 7 µl/ min). Interestingly, the extent of blood flow decrease within the untreated hindlimb seen in WT control animals, was significantly lower in WT mice receiving RRO (Δ decrease for CIA 0 ± 6%; p < 0.01), Table 1 Vascular morphology: (A) Overview of vascular morphology of medial upper hindlimb on day 14 after hindlimb ischemia. Presented are values of morphologic changes in vessel diameter (caudal femoral artery (B) and gracilis artery (C) of both hindlimbs on day 14 after induction of hindlimb ischemia with RRO or control (Ctr). Presented are absolute changes (µm) and relative lumen expansion of the ischemic in relation to the contralateral hindlimb (%). (n = 8; values are mean and SD; # p-value of Δ dilation (%); * p-value vs. WT indicating additional positive vascular effects on the site of repetitive occlusion. This effect was not seen in mice receiving L-NAME or NOS3
−/− -mice.
RRO-mediated arteriogenesis improves hindlimb perfusion
To assess the functional relevance of RRO-stimulated collateral expansion, we performed serial perfusion measurements using laser Doppler on the same animal over a period of 14 days. After an initially precipitous reduction in perfusion of the ischemic hindlimb, we documented a modest perfusion recovery in all groups over the first 3 days. RRO however, led to a more sustained perfusion increase in the course of recovery as compared to control mice. Thus, leading to a significant improvement of hindlimb perfusion after 14 days (58 ± 14% for mice subjected to RRO vs. 47 ± 8% for control mice; p < 0.0001; Fig. 5 ). The time course of recovery in mice receiving L-NAME and in eN-OS3 -/-mice, however, was much flatter and the levels of perfusion on day 14 were significantly lower compared to control mice (L-NAME: 34 ± 6%, p < 0.001; eNOS3 -/-: 32 ± 2%, p < 0.001). Induction of RRO in either group did not lead to a significant improvement of perfusion recovery (L-NAME+RRO: 34 ± 2%, p < 0.0001; eNOS3 -/-+ RRO; 31 ± 4%, p < 0.0001).
We the investigated the role of NO and applied the NO scavenger ODQ to mice prior to induction of hindlimb ischemia and during recovery. Our results showed that the recovery of hindlimb perfusion was greatly attenuated with ODQ (27 ± 6%, p [vs WT control] < 0.001) to a similar degree as observed with L-NAME (p [ODQ vs L-NAME] > 0.05) and in NOS3 To evaluate a role of cGMP, we also performed additional hindlimb ischemia experiments with and without RRO in the presence of the sGC activator cinaciguat. Our results showed that the recovery of hindlimb perfusion was significantly increased with cinaciguat (53 ± 3%) to a similar degree as observed with RRO in WT (p [cinaciguat vs WT+ RRO] > 0.05) and that additional RRO to cinaciguat (56 ± 2%) did not lead to an additional increase over cinaciguat (p [cinaciguat vs cinaciguat + RRO] > 0.05). We interpret the results that the effects of cinaciguat and RRO may be mediated by a similar mechanism (i.e. NOcGMP) that is saturated by either treatment in these young animals.
Acute remote occlusion improves blood flow to the contralateral CFA in humans
In a proof-of-concept study, we subjected volunteers (n = 8) with known atherosclerotic vascular disease to acute remote occlusion over five minutes by inflation of a blood pressure cuff placed around the thigh (pressure 200 mmHg). Similar to the results in mice, simultaneous measurements of diameter and flow velocity of the contralateral CFA showed an almost immediate significant increase in blood flow velocity after cuff inflation that was followed by increased diameter and blood flow (Fig. 6A) . The flow velocity and WSS increase led to a delayed, likely flow-mediated, dilation of the CFA (Fig. 6B) reaching maximum dilation at four minutes after cuff inflation (Δ +8 ± 4%, p < 0.05). This was paralleled by an increased blood flow to the contralateral leg during cuff occlusion with a maximum at three minutes after cuff inflation (corresponding to Δ of 480 ± 360 ml/min, p < 0.05 vs baseline). Over the time of five minutes, flow velocity gradually decreased while the diameter and blood flow remained elevated. Cuff deflation led to a second short flow velocity acceleration, followed by gradual deceleration reaching baseline flow velocity approximately three minutes after deflation.
RRO improves walking distance in patients with PAD
In order to further investigate the potential of RRO in a setting of PAD, 4 patients with documented unilateral occlusion of the superficial femoral artery were instructed to perform RRO with a blood pressure cuff at home (repetitive cuff inflation to 200 mmHg on the contralateral thigh) over 12 weeks (every other day over five min followed by five min rest, 4x /day). The 4 control patients did not receive RRO (Fig. 7) . After 12 weeks, the patients in the RRO-group showed a significant improvement in ankle brachial index and walking distance as measured by six minute walking test (6MWT) compared to the control group (Δ +57.75 ± 14 m vs. Δ +10.5 ± 9 m; p = 0.04). The baseline readings of 6MWT did not differ between the groups (381 ± 45 m vs. 366 ± 36 m; p = 0.8).
Table 2
Changes in blood flow (%) within the vascular tree (common iliac artery, common femoral artery, caudal femoral artery) of both hindlimbs on day 14 after induction of unilateral hindlimb ischemia (values presented in relation to blood flow on day 2 after induction of hindlimb ischemia). (n = 8, values are mean and SD; # p-value Δ flow; * p-value vs WT [Ctr.]).
contralateral ischemic hindlimb group Δ flow (%) p-value # p-value (vs WT Ctr.) * Δ flow (%) p-value # p-value (vs WT Ctr.) * common iliac artery WT − 10 ± 6 < 0.0001 14 ± 4 < 0.0001 WT (+RRI) 0 ± 6 0.5 ≤ 0.01 27 ± 5 < 0.0001 < 0.0001 L-NAME (Ctr.) − 14 ± 5 < 0.0001 0.08 6 ± 2 < 0.01 < 0.05 L-NAME (+RRI) − 13 ± 5 < 0.0001 0.1 8 ± 3 < 0.01 < 0.05 NOS3 -/-(Ctr.) − 12 ± 5 < 0.0001 0.06 10 ± 12 < 0.0001 0.07 NOS3 -/-(+RRI) − 9 ± 2 < 0.001 0.08 12 ± 2 < 0.0001 0.09 common femoral artery WT − 15 ± 3 < 0.0001 28 ± 7 < 0.0001 WT (+RRI) − 5 ± 3 0.34 ≤ 0.01 63 ± 12 < 0.0001 < 0.0001 L-NAME (Ctr.) − 13 ± 7 < 0.001 0.25 12 ± 9 < 0.0001 < 0.01 L-NAME (+RRI) − 15 ± 5 < 0.001 0.08 9 ± 6 < 0. 
Discussion
The key results of the present work are that in the standard mouse model of hindlimb ischemia, remote occlusion led to immediate vasodilation and increased perfusion of the chronically ischemic hindlimb already during occlusion. Further, remote occlusion did not affect central hemodynamics, and the increased perfusion was sustained after reperfusion. RRO stimulated lumen expansion and increased blood flow Fig. 4 . Vessel diameter and flow velocity (series 2). Determination of vessel diameter and mean flow velocity by high-resolution ultrasound served to calculate flow volume. Presented are flow volumes of the iliac artery (1st row, hindlimb inflow) the common femoral artery (2nd row) and the caudal femoral artery (3rd row, collateral inflow) of each hindlimb (untreated hindlimb = plain; ischemic hindmlimb = striped). WT control (green), mice receiving RRO daily (blue), L-NAME in drinking water ad libitum (purple), L-NAME + daily RRO-intervention (turquois), NOS3
-/-(orange) and NOS3 -/-+ RRO (red). (n = 8 per group; symbols are mean and SD; # p < 0.05 vs contralateral hindlimb at same timepoint, * p < 0.05 vs day 2 post OP same limb).
in arteries (CIA, CFA) feeding into collaterals (CA) and the developing collateral arteries (GA) themselves resulting in improved perfusion of tissue. The effects of RRO, however, were largely abolished in mice treated with L-NAME, in NOS3 −/− animals, and with ODQ while stimulation of sGC with cinaciguat led to a similar response as RRO but was not additive. In our proof-of-concept studies in humans with vascular disease, we demonstrated that contralateral occlusion can acutely increase blood flow to an ischemic limb and increase walking capacity if applied repetitively in PAD. It was our first finding that the perfusion of an ischemic hindlimb acutely increases during occlusion of the contralateral non-ischemic leg. Our data identified 2 phases of the response. The almost immediate increase in blood flow was mainly due to increased flow velocity in the upstream inflow vessels (CIA and CFA) of the ischemic hindlimb indicating dilation of downstream resistance arteries. This increase in flow velocity which went along with increased WSS was then followed by the second phase of inflow artery dilation. The upstream vasodilation of CIA and CFA could be explained by flow-dependent vasodilation as the time course follows with a short delay the changes in flow velocity, which goes along with increased WSS similar to FMD [21] [22] [23] . Our preliminary human proof-of-concept study showed very similar responses in humans. Our data unambiguously demonstrate that the aortic blood pressure, heart rate, and stroke volume were not affected ruling out central hemodynamic effects of RRO. Several mechanisms may contribute to the biphasic protective role of RRO: (1.) The occlusion of the non-ischemic hindlimb may instantaneously redistribute blood volume to the conduit arteries of the diseased hindlimb. (2.) A so far unidentified neurogenic vasodilation of the microcirculation within the ischemic hindlimb in response to remote occlusion may contribute to the instantaneous increase in WSS and flow velocity within the CIA and CFA. (3.) The subsequent increase in the diameter of the CIA and CFA with further increase in blood flow into the diseased leg is mediated by localized activation of eNOS in the supplying conduit arteries. (4.) The sustained response, also after cuff release, may be additionally mediated by circulating messengers of remote conditioning, such as nitrite (7) .
Increased flow velocity triggering WSS has been shown across almost all species to be the initial stimulus to collateral expansion [9] [10] [11] . Our current results support this and demonstrate that RRO stimulated increased blood flow and WSS in arteries feeding into collaterals (CA) and within the developing collateral arteries (GA) themselves, followed by lumen expansion and resulting in sustained improvement of perfusion. Notably, no limb loss was observed in RRO mice. We submit that the observed collateral expansion may be triggered by the repetitive WSS stimulus, which in turn locally releases NO and leads to acute vasodilation, but also other more sustained cell signaling events. This is supported by the fact that the effects of RRO were largely abolished in mice treated with L-NAME and in NOS3 −/− -animals but also NO scavenging with ODQ. We and others have previously shown that both L-NAME and NOS3 −/− do greatly abrogate flow-mediated dilation of murine hindlimb conduit arteries but not microvascular dilation [18, 19] . Furthermore, our data suggest that the effect of RRO on reperfusion recovery may be mediated by a mechanism involving cGMP as cinaciguat led to a similar response as RRO in control animals but was not additive to RRO. We cannot, however, exclude that the chronic responses may also be mediated by soluble factors released after reperfusion, in particular nitrite. NOS3
, pharmacological NOS inhibition, or NO scavenging would also inhibit nitrite release after reperfusion [8, 24] .
Our current model of RRO supplements and expands the concept of Remote Ischemic Preconditioning (RIPC). RIPC describes the phenomenon in which transient non-temporary ischemia of one organ or tissue confers resistance to a subsequent event of ischemia reperfusion injury in a remote organ or tissue [25] . Several studies demonstrated beneficial effects of brief limb ischemia in preconditioning the heart resulting in smaller myocardial infarct size in animal models and reduced myocardial enzymes [26, 27] or lower endothelial injury in humans [28] . However, the protective effect of RIPC is believed to be mediated by either release of biochemical messengers in the circulation or activation of nerve pathways, resulting in release of messengers that have protective effect. Adenosine, NO, PKC, bradykinins, catecholamines, opioids, free radicals, and cytokines are candidate mechanisms that form part of a complex cascade involved in transduction of the preconditioning effect with overlap between neurogenic and humoral pathways. In contrast to RRO, RIPC is known to be either applied before, during, or shortly after the ischemic event and its positive effect was rather shown to dependent on successful revascularization of the occluded vessel. Thus, our model extends the concept of remote Following unilateral induction of hindlimb ischemia, laser Doppler imaging of both hindlimbs was performed to monitor vascular regeneration. Mice were subjected to RRO daily (8 × 5 min cuff occlusion) or shame ischemia to the healthy contralateral hindlimb: wild type (WT, dark green), WT + RRO (blue), L-NAME (purple), L-NAME + RRO (turquois), NOS3
-/-(orange), NOS3 -/-+ RRO (red), ODQ (light green), ODQ + RRO (pink), cinaciguat (beige), cinaciguat + RRO (brown). Values measured by laser Doppler imaging presented in relation to baseline values prior to induction of hindlimb ischemia (n = 8 per group; symbols are mean and SD; * p < 0.05, *** p < 0.001, and **** p < 0.0001vs WT).
ischemia and suggests that occlusion of a limb leads to contralateral resistance vessel vasodilation, increase in blood inflow, WSS, flowmediated dilation, and stimulates arteriogenesis in the remote organ when applied repetitively.
Limitations
Limitations of our animal data relate to the fact that blood flow and shear stress were calculated based on Doppler data and that we were not able to identify the exact mechanism by which an occlusion of one hindlimb leads to increased inflow into the other limb other than that it depends on eNOS and NO and was similar to but not additive to sGC activation in mice. Potential contributors of increased eNOS activity secondary to flow increases may be modulations of eNOS coupling status or changes in activity or expression of antioxidant enzymes such as SOD or catalase. Furthermore, our human studies are proof-of-concept studies that warrant confirmation. Despite promising results, the limitations include the small n-values, the fact that inherently proper blinding could not be ensured, and that we do not provide imaging data to further characterize collateral expansion as the cause for the improvement in walking distance.
Conclusions
Our current data show that in chronic hindlimb ischemia, remote contralateral occlusion (RRO) acutely stimulates blood flow and induces functional collateral expansion when applied repetitively via a NOS3-dependent mechanism. We submit that remote repetitive occlusion may be a feasible approach to non-invasively enhance arteriogenesis in PAD patients either in patients that cannot undergo revascularization or as an adjuvant option. 
